Charles Schwab Investment Management Inc Immunome Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Immunome Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 442,477 shares of IMNM stock, worth $4.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
442,477
Previous 139,561
217.05%
Holding current value
$4.19 Million
Previous $1.69 Million
283.23%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$54.6 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$46.4 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$36.8 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$35.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$33.1 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $115M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...